FDA Authorizes Mix-and-Match for COVID Booster Shots
Thursday, October 21, 2021
The Food and Drugs Administration (FDA) on Wednesday gave its approval for people to get booster shots that are different from the COVID vaccine they initially received.
The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:
The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID-19
- 18 through 64 years of age with frequent institutional or occupational exposure toSARS-CoV-2
The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.
“Today’s actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic,” said Acting FDA Commissioner Janet Woodcock, M.D.
“As the pandemic continues to impact the country, science has shown that vaccination continues to be the safest and most effective way to prevent COVID-19, including the most serious consequences of the disease, such as hospitalization and death," Woodcock added. "The available data suggest waning immunity in some populations who are fully vaccinated. The availability of these authorized boosters is important for continued protection against COVID-19 disease.”
This story was first published 10/20/21 6:48 PM
Related Articles
- What You Need to Know About COVID Booster Shots
- Pfizer Vaccine Safe and Effective in Children Ages 5 to 11, Announces Company
- Rise of the Delta Variant Calls for Re-Doubling Efforts to Overcome Vaccine Hesitancy - Horowitz
- FDA Grants Full Approval to Pfizer COVID-19 Vaccine
- Vaccine Hesitancy Remains a Problem - Rob Horowitz
- Treasurer Magaziner Calls for Vaccine Requirement for Teachers and School Staff in RI
- CVS & Walgreens Have Wasted Nearly 130,000 Vaccine Doses, According to Report
- Vaccine Reluctance – Dr. Ed Iannuccilli
- No Penalties for Letting Board Members Jump Vaccine Line: Inaction by Neronha Against CNE & Lifespan
- COVID Vaccine “100%” Effective in Kids 12-15, Says Pfizer
